-
MDI Biological Laboratory to Expand Innovative Data Literacy Program
Dec 31, 2019, 10:57 AM by Michael CroftBAR HARBOR, ME, UNITED STATES - Dec 31, 2019 - The MDI Biological Laboratory has announced that it is expanding its innovative SEPA (Science Education Partnership Award) program, which aims to improve secondary school education in data literacy while addressing the public health threat posed by arsenic in well waterFull story -
X4 Pharmaceuticals Initiates Phase 1b Clinical Trial of Mavorixafor in Combination with Ibrutinib for the Treatment of Waldenström’s Macroglobulinemia (WM)
Dec 30, 2019, 08:55 AM by Michael CroftCAMBRIDGE, MA, UNITED STATES - Dec 30, 2019 - X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today announced the initiation of a Phase 1b clinical trial of mavorixafor (X4P-001) in combination with ibrutinib (Imbruvica®) for the treatment of Waldenströms macroglobulinemia (WM), a rare form of non-Hodgkins lymphomaFull story -
Creative Diagnostics Launches Hepatitis B Virus Surface Antigen Mutants for Bio-research
Dec 29, 2019, 03:30 AM by Michael CroftSHIRLEY, NY - Dec 31, 2019 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics recently announced the launch of Hepatitis B Virus Surface Antigen Mutants manufacture platform using Yeast expression systemFull story -
Caris, GenScript, Fuzionaire, and More: News From December 2019
Dec 23, 2019, 09:10 AM by Michael CroftBio-IT World | December featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Caris, GenScript, Fuzionaire, and more.Full story -
A Digital Transformation at the City of Hope
Dec 19, 2019, 09:05 AM by Michael CroftFull storyBio-IT World | City of Hope National Medical Center’s Chief Digital Officer discusses his role at City of Hope, the changing point-of-care landscape, and future digital transformations for the industry.
-
Everest Medicines Announces Approval of Nefecon’s Clinical Trial Application by the China National Medical Products Administration
Dec 18, 2019, 16:29 PM by Michael CroftNEW YORK, NY - Dec 18, 2019 - Shanghai, China – December 18, 2019 – Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other parts of Asia, today announced it has received Clinical Trial Application (CTA) approval from the China National Medical Products Administration to conduct clinical trials for Nefecon in ChinaFull story -
A Regulatory View of Personalized Therapeutics
Dec 18, 2019, 09:10 AM by Michael CroftFull storyBio-IT World | The FDA’s Director of the Center for Biologics Evaluation and Research discusses the obstacles in developing gene therapies, emerging developments in the field, and the regulatory landscape surrounding personalized therapeutics.
-
KCR adopts Veeva Vault Clinical Suite
Dec 17, 2019, 15:44 PM by Michael CroftBOSTON - Dec 17, 2019 - KCR adopts Veeva Vault Clinical SuiteThe robust cloud platform will allow enhanced integration of trial management and documentation services through these new CTMS and eTMF solutionsFull story -
Microway Helps Enable Next-Level Research and Education at Oregon State University
Dec 17, 2019, 13:31 PM by Michael CroftPLYMOUTH, MA, UNITED STATES - Dec 17, 2019 - Microway, a leading provider of computational clusters, servers, and workstations for AI and HPC applications, announces it has provided Oregon State University with six NVIDIA® DGX-2 supercomputer systems, deployment services, and bringup expertiseFull story -
Accumen Launches Healthcare Performance Publication
Dec 17, 2019, 11:26 AM by Michael CroftPHOENIX, AZ - Dec 16, 2019 - Accumen Inc., the leader in healthcare performance, has launched the Healthcare Performance Insider, a monthly publication and website, providing operational, clinical and data insights from across the healthcare industryFull story -
Signant Health Appoints Paul Drake as Chief Compliance and Security Officer
Dec 17, 2019, 09:03 AM by Michael CroftPHILADELPHIA, PA - Dec 17, 2019 - Signant Health, announced today that it has appointed Paul Drake, PhD, MSc, as Chief Compliance and Security OfficerFull story -
GoZone WiFi and Safari Events Deliver Connected Shopping Experience at American Dream Megamall
Dec 17, 2019, 08:40 AM by Michael CroftST. PETERSBURG, FL, UNITED STATES - Dec 17, 2019 - GoZone WiFi (GoZone), the leading North American venue intelligence company, in partnership with Safari Event Services (Safari), today announced the deployment of their WiFi analytics and marketing solutions at the American Dream retail complex in East Rutherford, New JerseyFull story -
MR Solutions participates in the first nanomedicine joint annual meeting in Dijon
Dec 17, 2019, 06:16 AM by Michael CroftGUILDFORD, UNITED KINGDOM - Dec 17, 2019 - UK based MR Solutions presented a simultaneous 7T PET/MRI preclinical imaging system optimized for nanoparticle imaging to the first joint annual congress of the French Nanomedicine Society (SFNano), and the French national Competency Cluster in Nanoscience CNano which was held in Dijon in early DecemberFull story -
ZEISS wins R&D 100 Award for Superresolution Microscope
Dec 16, 2019, 14:03 PM by Michael CroftBOSTON, MA, UNITED STATES - Dec 3, 2019 - ZEISS is among the winners of the prestigious R&D 100 Awards 2019, with judges from R&D Magazine selecting ZEISS Elyra 7 with Lattice SIM for superresolution microscopy as an award recipient in the Analytical/Test categoryFull story -
BioIVT Announces the Launch of its Next-generation Sequencing Service
Dec 16, 2019, 11:20 AM by Michael CroftFull storyBio-IT World News Brief | BioIVT today launched its Next-generation Sequencing (NGS) Service, which combines the company’s expertise in human tissue procurement, specimen selection, sample preparation and project management with its in-house NGS capabilities.
-
IVF to Remain Technology of High Interest in Assisted Reproductive Technology Market, Finds Fact.MR
Dec 16, 2019, 09:09 AM by Michael CroftDUBLIN 2, IRELAND - Dec 16, 2019 - In-vitro fertilization (IVF) technology would account for an unrivalled patient base, as compared to surrogacy and artificial insemination, on the back of the high success rate of the procedureFull story -
Identifying Opportunities At The Interface Of Life Sciences And Tech
Dec 16, 2019, 07:25 AM by Michael CroftFull storyBio-IT World | Geraldine A. Van der Auwera calls herself a benevolent dictator. She boasts the pedigree of pre-doctoral and postdoctoral years in microbiology labs, and then a shift into computation. Now, as Director of Outreach and Communications, Data Sciences Platform, at the Broad Institute, she works with all camps—scientists, biomedical researchers, data scientists, technologists.
-
LIQUID STABLE HDL CHOLESTEROL CALIBRATION VERIFICATION KIT AVAILABLE FROM VERICHEM LABORATORIES
Dec 13, 2019, 16:38 PM by Michael CroftPROVIDENCE, RI - Dec 13, 2019 - VERICHEM LABORATORIES is pleased to announce the availability of fully liquid stable test kit intended for the calibration verification of both HDL and LDL cholesterol assaysFull story -
Vyasa Analytics, the Deep Learning Artificial Intelligence Solutions Provider, Joins Pistoia Alliance
Dec 13, 2019, 15:40 PM by Michael CroftBOSTON, MA, UNITED STATES - Dec 12, 2019 - Vyasa Analytics, an innovative provider of highly scalable deep-learning A.I. analytics software, today announced its membership in the Pistoia Alliance, a global, not-for-profit organization empowering healthcare and life sciences organizations to work together to lower the barriers to research and development (R&D) and discover breakthroughs in their fieldsFull story -
An AI-Based Evolution of Clinical Communities
Dec 13, 2019, 10:05 AM by Michael CroftFull storyBio-IT World | AI can bring efficacious, precise, and effective diagnostics and therapeutics faster to the patient, and in the future, more efficient operations could save money, freeing up capital to invest in innovation.